Lung Cancer Surgery Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Lung Cancer Surgery Market

1.1. Definition and Scope

1.1.1. Definition of Lung Cancer Surgery

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Lung Cancer Surgery Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Lung Cancer Surgery Market By Product

1.2.3. Lung Cancer Surgery Market By Procedure

1.2.4. Lung Cancer Surgery Market By End-User

1.2.5. Lung Cancer Surgery Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Lung Cancer Surgery Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Lung Cancer Surgery Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Lung Cancer Surgery Market By Product

4.1. Introduction

4.2. Lung Cancer Surgery Revenue By Product

4.2.1. Lung Cancer Surgery Revenue (USD Billion) and Forecast, By Product, 2018-2030

4.2.2. Surgical Instruments

4.2.2.1. Surgical Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.2. Powered Surgical Instruments

4.2.2.2.1. Powered Surgical Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.3. Hand Instruments

4.2.2.3.1. Hand Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3. Monitoring And Visualization System

4.2.3.1. Monitoring And Visualization System Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 5. Lung Cancer Surgery Market By Procedure

5.1. Introduction

5.2. Lung Cancer Surgery Revenue By Procedure

5.2.1. Lung Cancer Surgery Revenue (USD Billion) and Forecast, By Procedure, 2018-2030

5.2.2. Thoracotomy

5.2.2.1. Thoracotomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.2. Lobectomy

5.2.2.2.1. Lobectomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.3. Sleeve Resection

5.2.2.3.1. Sleeve Resection Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.4. Segmentectomy

5.2.2.4.1. Segmentectomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.5. Pneumonectomy

5.2.2.5.1. Pneumonectomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Minimally Invasive Surgeries

5.2.3.1. Minimally Invasive Surgeries Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Lung Cancer Surgery Market By End-User

6.1. Introduction

6.2. Lung Cancer Surgery Revenue By End-User

6.2.1. Lung Cancer Surgery Revenue (USD Billion) and Forecast, By End-User, 2018-2030

6.2.2. Hospitals/Clinics

6.2.2.1. Hospitals/Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Ambulatory Surgical Centers

6.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Research Laboratories

6.2.4.1. Research Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Lung Cancer Surgery Market By Country 

7.1. North America Lung Cancer Surgery Market Overview

7.2. U.S.

7.2.1. U.S. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

7.2.2. U.S. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

7.2.3. U.S. Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

7.3. Canada

7.3.1. Canada Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

7.3.2. Canada Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

7.3.3. Canada Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Lung Cancer Surgery Market By Country

8.1. Europe Lung Cancer Surgery Market Overview

8.2. U.K.

8.2.1. U.K. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

8.2.2. U.K. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

8.2.3. U.K. Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

8.3. Germany

8.3.1. Germany Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

8.3.2. Germany Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

8.3.3. Germany Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

8.4. France

8.4.1. France Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

8.4.2. France Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

8.4.3. France Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

8.5. Spain

8.5.1. Spain Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

8.5.2. Spain Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

8.5.3. Spain Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

8.6.2. Rest of Europe Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

8.6.3. Rest of Europe Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Lung Cancer Surgery Market By Country

9.1. Asia Pacific Lung Cancer Surgery Market Overview

9.2. China

9.2.1. China Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

9.2.2. China Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

9.2.3. China Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.3. Japan

9.3.1. Japan Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

9.3.2. Japan Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

9.3.3. Japan Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.4. India

9.4.1. India Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

9.4.2. India Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

9.4.3. India Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.5. Australia

9.5.1. Australia Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

9.5.2. Australia Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

9.5.3. Australia Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.6. South Korea

9.6.1. South Korea Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

9.6.2. South Korea Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

9.6.3. South Korea Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

9.7.2. Rest of Asia-Pacific Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

9.7.3. Rest of Asia-Pacific Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Lung Cancer Surgery Market By Country

10.1. Latin America Lung Cancer Surgery Market Overview

10.2. Brazil

10.2.1. Brazil Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

10.2.2. Brazil Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

10.2.3. Brazil Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.3. Mexico

10.3.1. Mexico Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

10.3.2. Mexico Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

10.3.3. Mexico Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

10.4.2. Rest of Latin America Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

10.4.3. Rest of Latin America Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Lung Cancer Surgery Market By Country 

11.1. Middle East & Africa Lung Cancer Surgery Market Overview

11.2. GCC

11.2.1. GCC Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

11.2.2. GCC Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

11.2.3. GCC Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.3. South Africa

11.3.1. South Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

11.3.2. South Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

11.3.3. South Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030

11.4.2. Rest of Middle East & Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030

11.4.3. Rest of Middle East & Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Lung Cancer Surgery Market

12.1. Lung Cancer Surgery Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Lung Cancer Surgery Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Ethicon LLC

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Billion), 2021

13.1.3.2. Ethicon LLC 2021 Lung Cancer Surgery Business Regional Distribution

13.1.4. Product /Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Intuitive Surgical, Inc.

13.3. Karl Storz GmbH & Co. KG

13.4. Olympus Corporation

13.5. Accuray Inc.

13.6. AngioDynamics Inc.

13.7. Teleflex Incorporated

13.8. Ackermann Instrumente GmbH

13.9. Medtronic Plc.

13.10. Siemens Healthcare

13.11. Surgical Holdings

13.12. Wexler Surgical Inc

13.13. Covidien PLC

13.14. Scanlan International Inc.